Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-21

FDA Approved: VELTASSA — Original Application (Vifor Pharma, Inc.)

View source ↗

Summary

FDA approved VELTASSA (patiromer) from Vifor Pharma via the original NDA for the treatment of hyperkalemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Veltassa (patiromer)

Snippet

ORIG AP for VELTASSA (PATIROMER)